DGAP-CMS: Siemens Healthineers AG: Release of a capital market information
2021. július 12., hétfő, 15:00
Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052 Share buyback - 2nd Interim Reporting In the time period from and including 05 July 2021 until and including 09 July 2021, a number of 291,546 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 23 June 2021, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 28 June 2021. Shares were bought back as follows:
The transactions are published in a detailed form on the website of Siemens Healthineers AG (www.corporate.siemens-healthineers.com/investor-relations). The total volume of shares which were bought back within the framework of the share buyback in the time period from and including 28 June 2021 until and including 09 July 2021 amounts to 525,955 shares. The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA). Munich, 12 July 2021 Siemens Healthineers AG The Managing Board 1 Excluding incidental acquisition costs, rounded to four decimal places according to commercial practice.
|
Language: | English |
Company: | Siemens Healthineers AG |
Henkestr. 127 | |
91052 Erlangen | |
Germany | |
Internet: | https://www.corporate.siemens-healthineers.com |
End of News | DGAP News Service |
1217857 12.07.2021
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]